199 related articles for article (PubMed ID: 11566971)
1. Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site.
Douthwaite S; Champney WS
J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():1-8. PubMed ID: 11566971
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of ketolides vs. macrolides.
Douthwaite S
Clin Microbiol Infect; 2001; 7 Suppl 3():11-7. PubMed ID: 11523556
[TBL] [Abstract][Full Text] [Related]
3. The ketolides: a critical review.
Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
[TBL] [Abstract][Full Text] [Related]
4. Ketolides-telithromycin, an example of a new class of antibacterial agents.
Bryskier A
Clin Microbiol Infect; 2000 Dec; 6(12):661-9. PubMed ID: 11284926
[TBL] [Abstract][Full Text] [Related]
5. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Douthwaite S; Hansen LH; Mauvais P
Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
[TBL] [Abstract][Full Text] [Related]
6. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
Garza-Ramos G; Xiong L; Zhong P; Mankin A
J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the antibiotic activity of ketolides and azalides.
Schlünzen F; Harms JM; Franceschi F; Hansen HA; Bartels H; Zarivach R; Yonath A
Structure; 2003 Mar; 11(3):329-38. PubMed ID: 12623020
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for six ketolide antibiotics.
Champney WS; Tober CL
Curr Microbiol; 2001 Mar; 42(3):203-10. PubMed ID: 11270656
[TBL] [Abstract][Full Text] [Related]
9. The emerging new generation of antibiotic: ketolides.
Zhong P; Shortridge V
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):125-31. PubMed ID: 12455409
[TBL] [Abstract][Full Text] [Related]
10. Will resistance to ketolides develop in Streptococcus pneumoniae?
Leclercq R
J Infect; 2002 Feb; 44 Suppl A():11-6. PubMed ID: 12150490
[TBL] [Abstract][Full Text] [Related]
11. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
Hansen LH; Mauvais P; Douthwaite S
Mol Microbiol; 1999 Jan; 31(2):623-31. PubMed ID: 10027978
[TBL] [Abstract][Full Text] [Related]
12. Conformations in solution and bound to bacterial ribosomes of ketolides, HMR 3647 (telithromycin) and RU 72366: a new class of highly potent antibacterials.
Evrard-Todeschi N; Gharbi-Benarous J; Gaillet C; Verdier L; Bertho G; Lang C; Parent A; Girault JP
Bioorg Med Chem; 2000 Jul; 8(7):1579-97. PubMed ID: 10976506
[TBL] [Abstract][Full Text] [Related]
13. Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.
Ackermann G; Rodloff AC
J Antimicrob Chemother; 2003 Mar; 51(3):497-511. PubMed ID: 12615850
[TBL] [Abstract][Full Text] [Related]
14. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Champney WS; Tober CL
Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
[TBL] [Abstract][Full Text] [Related]
15. Review of macrolides and ketolides: focus on respiratory tract infections.
Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
[TBL] [Abstract][Full Text] [Related]
16. Recent developments on ketolides and macrolides.
Wu YJ; Su WG
Curr Med Chem; 2001 Dec; 8(14):1727-58. PubMed ID: 11562291
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into the antibiotic action of telithromycin against resistant mutants.
Berisio R; Harms J; Schluenzen F; Zarivach R; Hansen HA; Fucini P; Yonath A
J Bacteriol; 2003 Jul; 185(14):4276-9. PubMed ID: 12837804
[TBL] [Abstract][Full Text] [Related]
18. The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Champney WS; Pelt J
Curr Microbiol; 2002 Sep; 45(3):155-60. PubMed ID: 12177734
[TBL] [Abstract][Full Text] [Related]
19. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
[TBL] [Abstract][Full Text] [Related]
20. Ketolides: the future of the macrolides?
Nilius AM; Ma Z
Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
